Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of an MVA Vaccine Targeting P53 in Cancer

NCT01191684 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT01191684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01191684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of an MVA Vaccine Targeting P53 in Cancer
Lead sponsor
City of Hope Medical Center
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2011
Completion date
August 31, 2013
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent colon cancer, recurrent gastric cancer, recurrent pancreatic cancer, recurrent rectal cancer, stage iii colon cancer, stage iii gastric cancer, stage iii pancreatic cancer, stage iii rectal cancer, stage iv colon cancer, stage iv gastric cancer, stage iv pancreatic cancer, stage iv rectal cancer